⌘K

Login Start Free

Home/Filings/4/0000899243-19-017407

4//SEC Filing

Tasker Sybil 4

Accession 0000899243-19-017407

CIK 0001326190other

View on SEC.gov Company Profile

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:01 PM ET

Size

5.5 KB

Accession

0000899243-19-017407

Insider Transaction Report

Form 4

Period: 2019-06-17

Altimmune, Inc.ALT

Chief Medical Officer

Transactions

Award
Stock Options (option to buy)
2019-06-17+20,000→ 20,000 total
Exercise: $2.46Exp: 2024-06-17→ Common Stock, par value $0.0001 (20,000 underlying)

Footnotes (1)

[F1]100% of the shares will vest in 6 equal monthly installments, with the first vesting date on July 31, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1

filerCIK 0001705900

Filing Metadata

Form type: 4
Filed: Jun 18, 8:00 PM ET
Accepted: Jun 19, 4:01 PM ET
Size: 5.5 KB

View on SEC.gov